Compare · NFYS vs PRE
NFYS vs PRE
Side-by-side comparison of Enphys Acquisition Corp. (NFYS) and Prenetics Global Limited (PRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NFYS and PRE operate in Blank Checks (Finance), so they compete in similar markets.
- PRE carries a market cap of $270.0M.
- PRE has hit the wire 7 times in the past 4 weeks while NFYS has been quiet.
- PRE has more recent analyst coverage (8 ratings vs 0 for NFYS).
NFYS
Enphys Acquisition Corp.
Enphys Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Latest NFYS
- SEC Form NT 10-Q filed by Enphys Acquisition Corp.
- Enphys Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- Amendment: SEC Form SC 13G/A filed by Enphys Acquisition Corp.
- Enphys Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Enphys Acquisition Corp.
- SEC Form DEF 14A filed by Enphys Acquisition Corp.
- SEC Form NT 10-Q filed by Enphys Acquisition Corp.
- SEC Form PRE 14A filed by Enphys Acquisition Corp.
- SEC Form 10-K filed by Enphys Acquisition Corp.
- SEC Form NT 10-K filed by Enphys Acquisition Corp.
Latest PRE
- Director Leogrande Hudson Blake converted options into 2,000 units of Class A Ordinary Share, increasing direct ownership by 25% to 10,001 units (SEC Form 4)
- SEC Form 6-K filed by Prenetics Global Limited
- Care Bears And Prenetics' IM8 Announce Global Partnership
- SEC Form 6-K filed by Prenetics Global Limited
- Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
- SEC Form 6-K filed by Prenetics Global Limited
- Maxim Group initiated coverage on Prenetics Group Ltd. with a new price target
- SEC Form 6-K filed by Prenetics Global Limited
- IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
- SEC Form 4 filed by Prenetics Global Limited